Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes

AIMS: Missed diagnosis of maturity-onset diabetes of the young (MODY) has led to an interest in biomarkers that enable efficient prioritization of patients for definitive molecular testing. Apolipoprotein M (apoM) was suggested as a biomarker for hepatocyte nuclear factor 1 alpha (HNF1A)-MODY becaus...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mughal, S. A., Park, R., Nowak, N., Gloyn, A. L., Karpe, F., Matile, H., Malecki, M. T., McCarthy, M. I., Stoffel, M., Owen, K. R.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4193536/
https://ncbi.nlm.nih.gov/pubmed/23157689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.12066
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares